Publications of Yvonne Genzel
All genres
Journal Article (92)
21.
Journal Article
37 (47), pp. 7003 - 7010 (2019)
Semi-perfusion cultures of suspension MDCK cells enable high cell concentrations and efficient influenza A virus production. Vaccine 22.
Journal Article
37 (47), pp. 7011 - 7018 (2019)
Influenza A virus production in a single-use orbital shaken bioreactor with ATF or TFF perfusion systems. Vaccine 23.
Journal Article
Use of sulfated cellulose membrane adsorbers for chromatographic purification of cell cultured-derived influenza A and B viruses. Separation and Purification Technology (226), pp. 350 - 358 (2019)
24.
Journal Article
37 (47), pp. 7019 - 7028 (2019)
Efficient influenza A virus production in high cell density using the novel porcine suspension cell line PBG.PK2.1. Vaccine 25.
Journal Article
7, 275 (2019)
Production of Defective Interfering Particles of Influenza A Virus in Parallel Continuous Cultures at Two Residence Times—Insights From qPCR Measurements and Viral Dynamics Modeling. Frontiers in Bioengineering and Biotechnology 26.
Journal Article
14 (11), e0224317 (2019)
Continuous influenza virus production in a tubular bioreactor system provides stable titers and avoids the “von Magnus effect”. PLoS One 27.
Journal Article
103 (7), pp. 3025 - 3035 (2019)
High titer MVA and influenza A virus production using a hybrid fed-batch/perfusion strategy with an ATF system. Applied Microbiology and Biotechnology 28.
Journal Article
36 (22), pp. 3140 - 3145 (2018)
Propagation of Brazilian Zika virus strains in static and suspension cultures using Vero and BHK cells. Vaccine 29.
Journal Article
102 (20), pp. 8725 - 8737 (2018)
Process intensification of EB66 ® cell cultivations leads to high-yield yellow fever and Zika virus production. Applied Microbiology and Biotechnology 30.
Journal Article
9, 26 (2018)
Assessing the Importance of Domestic Vaccine Manufacturing Centers: An Overview of Immunization Programs, Vaccine Manufacture, and Distribution. Frontiers in immunology 31.
Journal Article
36 (22), pp. 3124 - 3133 (2018)
High-cell-density cultivations to increase MVA virus production. Vaccine 32.
Journal Article
102 (3), pp. 1167 - 1177 (2018)
Cell culture-based production of defective interfering particles for influenza antiviral therapy. Applied Microbiology and Biotechnology 33.
Journal Article
12 (8), e0182553 (2017)
Efficient and stable production of Modified Vaccinia Ankara virus in two-stage semi-continuous and in continuous stirred tank cultivation systems. PLoS One 34.
Journal Article
11 (10), pp. 1332 - 1342 (2016)
Ezrin and HNRNP expression correlate with increased virus release rate and early onset of virus-induced apoptosis of MDCK suspension cells. Biotechnology Journal 35.
Journal Article
113 (1), pp. 150 - 162 (2016)
Increased titer and reduced lactate accumulation in recombinant retrovirus production through the down-regulation of HIF1 and PDK. Biotechnology and Bioengineering 36.
Journal Article
100 (5), pp. 2121 - 2132 (2016)
Bioreactors for high cell density and continuous multi-stage cultivations: options for process intensification in cell culture-based viral vaccine production. Applied Microbiology and Biotechnology 37.
Journal Article
99 (17), pp. 7059 - 7068 (2015)
Production of canine adenovirus type 2 in serum-free suspension cultures of MDCK cells. Applied Microbiology and Biotechnology 38.
Journal Article
14 (9), pp. 1181 - 1191 (2015)
Bioreactor concepts for cell culture-based viral vaccine production. Expert Review of Vaccines 39.
Journal Article
10 (5), pp. 728 - 740 (2015)
Designing cell lines for viral vaccine production: Where do we stand? Biotechnology Journal 40.
Journal Article
33 (35), pp. 4269 - 4280 (2015)
Monitoring changes in proteome during stepwise adaptation of a MDCK cell line from adherence to growth in suspension. Vaccine